Shopping Cart
- Remove All
- Your shopping cart is currently empty
LOXL2 Protein, Human, Recombinant (His) is expressed in CHO Stable Cells. The accession number is Q9Y4K0.
Pack Size | Price | Availability | Quantity |
---|
Biological Activity | Measured by its ability to produce hydrogen peroxide during the oxidation of benzylamine. The specific activity is >2 pmol/min/μg |
Description | LOXL2 Protein, Human, Recombinant (His) is expressed in CHO Stable Cells. The accession number is Q9Y4K0. |
Protein Purity | ≥ 95% as determined by SDS-PAGE. ≥ 95% as determined by SEC-HPLC. |
Molecular Weight | 85.5 kDa (predicted) |
Research Background | Lysyl oxidase homolog 2, also known as Lysyl oxidase-like protein 2, Lysyl oxidase-related protein 2, Lysyl oxidase-related protein WS9-14 and LOXL2, is a secreted protein that belongs to the lysyl oxidase family. LOXL2 contains four SRCR domains. The lysyl oxidase family is made up of five members: lysyl oxidase (LOX) and lysyl oxidase-like 1-4 ( LOXL1, LOXL2, LOXL3, LOXL4 ). All members share conserved C-terminal catalytic domains that provide for lysyl oxidase or lysyl oxidase-like enzyme activity; and more divergent propeptide regions. LOX family enzyme activities catalyze the final enzymatic conversion required for the formation of normal biosynthetic collagen and elastin cross-links. LOXL2 is expressed by pre-hypertrophic and hypertrophic chondrocytes in vivo, and that LOXL2 expression is regulated in vitro as a function of chondrocyte differentiation. LOXL2 promotes chondrocyte differentiation by mechanisms that are likely to include roles as both a regulator and an effector of chondrocyte differentiation. LOXL2 expression could also be explored as a molecular target in the prevention of breast cancer progression. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.